AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Realbotix Corp.

$0.2 -$0.13 (-39.94%)
OTC · 15 Sep 2026 15:50 UTC
Previous Close
$0.2
Day Range
$0.2$0.2
Year Range
$0.17$0.47
Market Cap
43.15M
AVG Volume
234.7K
Trailing/Forward PE
-9.54/-
PEG ratio
0.13
Dividend Yield
-
Next Earnings Date
2026-10-27
Primary Exchange
Other OTCUS
Revenue (USD)
-500K0500K1M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q3345.23K
26 Q2222.03K
26 Q1358.46K
25 Q4-213.19K
25 Q3615.37K
25 Q2761.1K
25 Q1858.27K
24 Q4464.62K
24 Q3312.56K
24 Q2286.42K
Net Income (USD)
-15M-10M-5M05M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q3-1.77M
26 Q2381.88K
26 Q1-1.36M
25 Q4-882.68K
25 Q316.77K
25 Q2-4.85M
25 Q1903.19K
24 Q4-12.01M
24 Q3-2.5M
24 Q23.83M
Operating Income (USD)
-6M-4M-2M02M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q3-1.57M
26 Q2-2.11M
26 Q1-1.59M
25 Q4-2.08M
25 Q348.6K
25 Q2-4.93M
25 Q1726.04K
24 Q4-3.76M
24 Q3-2.55M
24 Q2-194.07K
EBITDA (USD)
-8M-6M-4M-2M02M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q3-1.46M
26 Q2-1.96M
26 Q1-1.17M
25 Q4-2.2M
25 Q3189.42K
25 Q2-4.68M
25 Q11.1M
24 Q4-6.36M
24 Q3-2.55M
24 Q2-227.6K
Cash Flows (USD)
-3M-2M-1M023 Q223 Q324 Q124 Q225 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q3-1.92M
26 Q2-1.25M
26 Q1-1.27M
25 Q4-2.21M
25 Q3-398.8K
25 Q2-1.18M
24 Q2-633.29K
24 Q1-512.03K
23 Q3-1.04M
23 Q2-757.97K
EPS (USD)
-0.1-0.0500.0524 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF EPS (USD) by quarter
PeriodEPS (USD)
26 Q3-0.01
26 Q20
26 Q1-0.01
25 Q4-0
25 Q30
25 Q2-0.02
25 Q10
24 Q4-0.08
24 Q3-0.02
24 Q20.03
Expenses (USD)
-4M-2M02MR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Expenses (USD) by quarter
PeriodExpenses (USD)
24 Q10
23 Q30
23 Q20
26 Q31.27M
26 Q21.78M
26 Q11.28M
25 Q4-3.59M
25 Q3929.88K
25 Q21.15M
25 Q11.52M
24 Q4152.33K
24 Q31.29M
24 Q2334.39K
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q35.19M
26 Q26.13M
26 Q17.33M
25 Q45.19M
25 Q31.85M
25 Q2991.71K
25 Q1930.81K
24 Q41.44M
24 Q31.6M
24 Q22.35M
Debt ratios
-4-20224 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Debt ratios by quarter
PeriodDebt ratios
26 Q30.67
26 Q21.17
26 Q10.91
25 Q40.64
25 Q30.01
25 Q2-0.08
25 Q1-0.15
24 Q4-0.11
24 Q3-0.1
24 Q2-3.29
Margins
-500%-250%0%250%500%750%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Margins by quarter
PeriodMargins
26 Q3-86.08%
26 Q2-259.45%
26 Q1-54.87%
25 Q4711.17%
25 Q339.2%
25 Q250.84%
25 Q146.41%
24 Q4-16.38%
24 Q345.93%
24 Q2-67.76%
Return on Capital
-150%-100%-50%0%50%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Return on Capital by quarter
PeriodReturn on Capital
26 Q3-26.65%
26 Q24.58%
26 Q1-17.68%
25 Q4-24.12%
25 Q30.35%
25 Q2-112.64%
25 Q19.96%
24 Q4-149.86%
24 Q3-13.3%
24 Q225.74%
Shares Outstanding
0100M200M300M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q3220.33M
26 Q2219.13M
26 Q1155.06M
25 Q4142.45M
25 Q3199.94M
25 Q2197.46M
25 Q1196.73M
24 Q4158.84M
24 Q3120.96M
24 Q2120.96M
Book Value Per Share (USD)
00.050.10.150.224 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q30.03
26 Q20.04
26 Q10.05
25 Q40.03
25 Q30.02
25 Q20.02
25 Q10.05
24 Q40.05
24 Q30.16
24 Q20.12
Total Assets (USD)
010M20M30M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
XBOTF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q38.03M
26 Q29.87M
26 Q19.08M
25 Q47.09M
25 Q37.49M
25 Q27.58M
25 Q112.75M
24 Q412.2M
24 Q323.46M
24 Q215.36M
Free Cash Flow Yield
-60%-40%-20%0%20%med -16.68%Jun 23Oct 23Jan 24May 24Aug 24Jun 26Sep 26
XBOTF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-11.98%
Sep 26-11.98%
Sep 26-11.53%
Aug 26-11.13%
Aug 26-10.75%
Aug 26-11.18%
Aug 26-11.13%
Jul 26-11.43%
Jul 26-9.83%
Jul 26-10.4%
Jul 26-8.8%
Jul 26-8.66%
Jun 26-16.3%
Jun 26-15.88%
Jun 26-15.56%
Jun 26-15.52%
May 26-12.77%
May 26-13.65%
May 26-14.52%
May 26-14.11%
May 26-13.13%
Apr 26-12.92%
Apr 26-13.35%
Apr 26-14.67%
Apr 26-15.36%
Sep 24-31.1%
Sep 24-31.18%
Sep 24-30.02%
Sep 24-28.81%
Aug 24-29.09%
Aug 24-26.72%
Aug 24-26.38%
Aug 24-24.39%
Aug 24-22.11%
Jul 24-20.86%
Jul 24-20.25%
Jul 24-19.45%
Jul 24-19.85%
Jun 24-16.25%
Jun 24-15.77%
Jun 24-13.23%
Jun 24-15.57%
May 24-17.92%
May 24-16.87%
May 24-17.23%
May 24-22.66%
May 24-23.15%
Apr 24-22.46%
Apr 24-21.54%
Apr 24-22.75%
Apr 24-21.77%
Mar 24-15.29%
Mar 24-16.66%
Mar 24-16.6%
Mar 24-15.04%
Mar 24-16.53%
Feb 24-20.09%
Feb 24-20.29%
Feb 24-20.67%
Feb 24-22%
Jan 24-16.7%
Jan 24-17.49%
Jan 24-16.53%
Jan 24-14.11%
Dec 23-12.63%
Dec 231.02%
Dec 231.13%
Dec 231.08%
Dec 231.07%
Nov 231.06%
Nov 231.13%
Nov 231.24%
Nov 231.08%
Oct 231.07%
Oct 231.12%
Oct 231.15%
Oct 231.04%
Sep 231.01%
Sep 23-32.31%
Sep 23-33.52%
Sep 23-33.29%
Sep 23-33.54%
Aug 23-29.71%
Aug 23-30.78%
Aug 23-27.91%
Aug 23-23.78%
Jul 23-20.79%
Jul 23-18.62%
Jul 23-20.5%
Jul 23-25.26%
Jun 23-26.72%
Jun 23-35.65%
Jun 23-47.15%
Jun 23-44.57%
Jun 23-41.08%
May 23-45.61%
May 23-48.25%
May 23-46.02%
May 23-41.41%
Apr 23-42.73%
Price to Sales
020406080med 23.62Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XBOTF Price to Sales by quarter
PeriodPrice to Sales
Sep 2643.51
Sep 2643.51
Sep 2645.2
Aug 2646.83
Aug 2648.5
Aug 2646.63
Aug 2646.83
Jul 2645.6
Jul 2653.03
Jul 2650.11
Jul 2659.25
Jul 2660.21
Jun 2620.37
Jun 2620.91
Jun 2621.34
Jun 2621.4
May 2626
May 2624.32
May 2622.87
May 2623.54
May 2625.29
Apr 2625.7
Apr 2624.86
Apr 2622.63
Apr 2621.61
Mar 2615.08
Mar 2614.94
Mar 2615.89
Mar 2614.04
Feb 2614.09
Feb 2614.67
Feb 2615.38
Feb 2616.86
Jan 2618.22
Jan 2620.96
Jan 2619.34
Jan 2619.29
Jan 2623.05
Dec 2522.36
Dec 2519.52
Dec 2519.92
Dec 2521.11
Nov 2522.7
Nov 2521.04
Nov 2518.5
Nov 2518.51
Oct 2522.96
Oct 2523.7
Oct 2530.17
Oct 2531.1
Oct 2526.35
Sep 2529.33
Sep 2530.11
Sep 2524.72
Sep 2524.72
Aug 2526.49
Aug 2523.89
Aug 2524.17
Aug 2525.54
Aug 2519.62
Jul 2521.46
Jul 2523.15
Jul 2523.37
Jul 2525.78
Jun 2530.68
Jun 2528.66
Jun 2529.69
Jun 2526.83
May 2530.71
May 2536.18
May 2529.69
May 2528.75
May 2520.47
Apr 2519.83
Apr 2518.43
Apr 2519.9
Apr 2516.77
Mar 2527.25
Mar 2528.12
Mar 2530.35
Mar 2531.6
Feb 2532.62
Feb 2538.4
Feb 2545.83
Feb 2540.07
Jan 2532.08
Jan 2534.38
Jan 2539.63
Jan 2551.65
Jan 2520.81
Dec 2421
Dec 2417.78
Dec 2415.7
Dec 2415.4
Nov 2413.55
Nov 2414.65
Nov 2417.06
Nov 2418.51
Nov 2418.18
Oct 2415.26
EV/EBITDA
-1001020med 4.26Aug 22Oct 22Jan 23Oct 23Apr 24Jul 24Sep 24
XBOTF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2410.71
Sep 2410.68
Sep 2411.21
Sep 2411.82
Aug 2411.68
Aug 2413
Aug 2413.22
Aug 2414.56
Aug 2416.41
Jul 2417.59
Jul 2418.21
Jul 2419.09
Jul 2418.64
Jun 244.08
Jun 244.23
Jun 245.23
Jun 244.3
May 243.61
May 243.89
May 243.79
May 242.65
May 242.57
Apr 242.68
Apr 242.84
Apr 242.63
Apr 242.8
Dec 236.05
Dec 235.12
Dec 235.5
Dec 235.63
Nov 235.64
Nov 235.1
Nov 234.33
Nov 235.52
Oct 235.56
Oct 235.22
Oct 234.99
Oct 235.85
Sep 236.12
Mar 235.29
Mar 235.84
Mar 234.67
Mar 237.32
Feb 236.49
Feb 238
Feb 238.11
Feb 238.06
Jan 238.39
Jan 2311.35
Jan 237.86
Jan 234.01
Dec 222.03
Dec 22-7.76
Dec 22-7.63
Dec 22-7.45
Dec 22-6.98
Nov 22-7.08
Nov 22-6.99
Nov 22-6.98
Nov 22-6.41
Oct 22-6.43
Oct 22-6.78
Oct 22-6.7
Oct 22-5.34
Sep 22-5.68
Sep 22-1.78
Sep 22-1.45
Sep 22-1.29
Sep 22-1.22
Aug 22-1.11
Aug 22-1.04
Aug 22-0.78
Aug 22-0.71
Jul 22-0.84
Jul 22-0.88
Jul 22-0.84
Jul 22-0.7
Jul 22-0.24
Price/Operating Cashflow
80859095100med 92.71Sep 23Oct 23Oct 23Nov 23Nov 23Dec 23Dec 23
XBOTF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Dec 2398.14
Dec 2388.53
Dec 2392.48
Dec 2393.74
Nov 2393.94
Nov 2388.35
Nov 2380.41
Nov 2392.71
Oct 2393.11
Oct 2389.61
Oct 2387.27
Oct 2396.07
Sep 2398.77
Price to Book
05101520med 6.27Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
XBOTF Price to Book by quarter
PeriodPrice to Book
Sep 265.13
Sep 265.13
Sep 265.33
Aug 265.52
Aug 265.72
Aug 265.5
Aug 265.52
Jul 265.38
Jul 266.25
Jul 265.91
Jul 266.98
Jul 267.1
Jun 264.02
Jun 264.13
Jun 264.21
Jun 264.22
May 265.13
May 264.8
May 264.51
May 264.64
May 264.99
Apr 265.07
Apr 264.91
Apr 264.47
Apr 264.26
Mar 268.33
Mar 268.25
Mar 268.78
Mar 267.75
Feb 267.78
Feb 268.1
Feb 268.5
Feb 269.31
Jan 2610.06
Jan 2611.58
Jan 2610.68
Jan 2610.66
Jan 2612.73
Dec 2512.73
Dec 2511.12
Dec 2511.34
Dec 2512.02
Nov 2512.92
Nov 2511.98
Nov 2510.53
Nov 2510.54
Oct 2513.07
Oct 2513.49
Oct 2517.17
Oct 2517.71
Oct 2515
Sep 2516.32
Sep 2516.75
Sep 2513.75
Sep 2513.75
Aug 2514.74
Aug 2513.29
Aug 2513.45
Aug 2514.21
Aug 2510.91
Jul 2511.94
Jul 2512.88
Jul 2513
Jul 2514.34
Jun 256.5
Jun 256.07
Jun 256.29
Jun 255.68
May 256.51
May 257.66
May 256.29
May 256.09
May 254.34
Apr 254.2
Apr 253.9
Apr 254.22
Apr 253.55
Mar 254.36
Mar 254.5
Mar 254.86
Mar 255.06
Feb 255.22
Feb 256.15
Feb 257.34
Feb 256.41
Jan 255.14
Jan 255.5
Jan 256.35
Jan 258.27
Jan 253.33
Dec 241
Dec 240.84
Dec 240.75
Dec 240.73
Nov 240.64
Nov 240.69
Nov 240.81
Nov 240.88
Nov 240.86
Oct 240.72
Realbotix Corp.
XBOTF
Stockpicker

Video analysis: XBOTF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XBOTF

Realbotix LLC Announces Bridge Loan from Onconetix

businesswire.com · 14 Sep 2026

Realbotix LLC Announces Bridge Loan from Onconetix

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, announces that its wholly owned subsidiary, Realbotix LLC, has entered into a loan agreement with Onconetix, Inc. (“Onconetix”) for an unsecured bridge loan facility in connection with the proposed merger transaction involving Realbotix LLC and Onconetix previously announced on February 12, 2026. The bridge loan provides transa.

Realbotix and European Telecom Company Launch Pilot to Expand Robot Capabilities in Live Presentations and Events

businesswire.com · 3 Sep 2026

Realbotix and European Telecom Company Launch Pilot to Expand Robot Capabilities in Live Presentations and Events

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, today announced a pilot with a leading European telecommunications company to put its humanoid robots in front of live audiences. The program will test how Realbotix robots can deliver presentations, support events, and hold interactive conversations in real social settings — not only one-on-one exchanges, but rooms full of peo.

Realbotix Corp. (XBOTF) Q3 2026 Earnings Call Transcript

seekingalpha.com · 12 Aug 2026

Realbotix Corp. (XBOTF) Q3 2026 Earnings Call Transcript

Realbotix Corp. (XBOTF) Q3 2026 Earnings Call Transcript

Realbotix Reports Financial Results for Q3-2026

businesswire.com · 12 Aug 2026

Realbotix Reports Financial Results for Q3-2026

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, reports its interim financial results for the three and nine months ended June 30, 2026 (“Q3-2026”). All dollar figures are reported in United States dollars (“USD”), unless otherwise stated. Realbotix Corp. is a holding company with two independently operated subsidiaries, Realbotix LLC and Intima LLC. While both leverage embe.

Realbotix Robot to Appear on Emmy Winning Television Show

businesswire.com · 6 Aug 2026

Realbotix Robot to Appear on Emmy Winning Television Show

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading manufacturer of humanoid robots and embedded AI systems, entered into an agreement with a recognized streaming platform to feature one of its robots as a robotic character in an upcoming episode of a popular Emmy awarded television series. The appearance is significant for Realbotix and highlights the growing cultural relevance of humanoid robotics in mainstream e.

Realbotix to Release its Q3-2026 Financial Results on August 12, 2026

businesswire.com · 5 Aug 2026

Realbotix to Release its Q3-2026 Financial Results on August 12, 2026

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, is pleased to share that it will release its interim financial results for the three and nine months ended June 30, 2026 (“Q3-2026”) on August 12, 2026. An investor webinar hosted by CEO Andrew Kiguel on Zoom has been scheduled to discuss the Company's Q3-2026 financial results starting at 3:00 pm ET on August 12, 2026. Date: A.

Realbotix Corp. Provides Corporate Structure and Operations Update

gurufocus.com · 22 Jul 2026

Realbotix Corp. Provides Corporate Structure and Operations Update

[url="]Realbotix Corp.[/url] (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Company") provides an overview of its corporate and operating

Realbotix Corp. Provides Corporate Structure and Operations Update

businesswire.com · 22 Jul 2026

Realbotix Corp. Provides Corporate Structure and Operations Update

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Company") provides an overview of its corporate and operating structure. Realbotix Corp. is a holding company with two separately operated businesses: Realbotix LLC, which focuses on AI-powered humanoid robotics for commercial service sector applications, and Intima LLC, which focuses on direct-to-consumer products. Realbotix LLC and Intima LLC have different product offerings with no.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.